Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer

Frances M. Boyle*, Ian E. Smith, Joyce O'Shaughnessy, Bent Ejlertsen, Aman U. Buzdar, Pierre Fumoleau, William Gradishar, Miguel Martin, Beverly Moy, Martine Piccart-Gebhart, Kathleen I. Pritchard, Deborah Lindquist, Mayur Amonkar, Yingjie Huang, Erica Rappold, Lisa S. Williams, Jing Wang-Silvanto, Tomomi Kaneko, Dianne M. Finkelstein, Paul E. Goss

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences